Clinical trial

Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction

NCT02779634

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record ubiquinol Normalized identity: ubiquinolView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-07-01

PhasePHASE2

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

ubiquinolDRUG · verified · RxNorm: ubiquinol

PlaceboDRUG

Sponsors & collaborators

Hadassah Medical Organizationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02779634 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.